Reporter

Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Net income rises for Partners HealthCare System

By Robert Weisman , Globe Staff

Earnings rose despite a state decision to drop an assessment on the insurer’s newly acquired health insurance division.

Novartis, Amgen join venture fund

By Robert Weisman , Globe Staff

Biopharmaceutical companies Novartis AG and Amgen Inc. have signed on as limited partners in a new $265 million venture capital fund.

Algeta wins FDA approval for prostate cancer treatment

By Robert Weisman , Globe Staff

The drug, called Xofigo, treats castration-resistant prostate cancer, a disease that afflicts tens of thousands of men in the US.

State health insurers post mixed financial results

By Robert Weisman , Globe Staff

Two of the state’s biggest health insurance companies reported income gains, one registered lower earnings, and one posted a loss.